Wednesday September 27^th

13.25-13.30 pm - Opening

Welcome and introduction: Pr Eric Deutsch, Director of Gustave Roussy Radiation Oncology Department and INSERM UMR 1030

PRIMER ON CANCER IMMUNOLOGY, RADIATIONS AND IMMUNOTHERAPY

(Educational Session)

13.30-15.30 Part I

• 30-14.00: INNATE IMMUNITY

Tumor-associated macrophages from bench to bedside, Pr Alberto Mantovani, Istituto Clinico Humanitas, IT

• 00-14.30: ADAPTIVE IMMUNITY

Role of tertiary lymphoid structures in response to anti-cancer immunotherapy, Pr Antoine Italiano, Gustave Roussy, FR

• 30-15.00: IMMUNOLOGICAL CELL DEATH

Immunological cell death: inducers and enhancers, Pr Guido Kroemer, Cordeliers Research Center, FR

• 00-15.30: ABSCOPAL EFFECT

Mechanisms of interaction of radiotherapy with immunotherapy, Pr Silvia Formenti, Weill Cornell Medicine, USA

15.30-16.00 Coffee break

16.00-18.00 Part II

• 00-16.30: CLINICAL IMMUNOTHERAPY

How to build on the top of current chemo-radiations and PD-L1 inhibitors? The NSCLC model, Pr Fabrice Barlési, Gustave Roussy, FR

• 30-17.00: DNA DAMAGE RESPONSE

Modulating DNA damage responses to enhance radiotherapy-immunotherapy combinations, Pr Kevin Harrington, Institute of Cancer Research, UK

• 00-17.30: RADIO-IMMUNOTHERAPY

Immunogenic cell death driven by radiotherapy – Mechanisms and implications, Dr Lorenzo Galluzzi, Weill Cornell Medicine, USA

MAIN PROGRAM

Keynote Presentation

• 30-18.15: AI for Cancer Precision Medicine, Pr Fabrice André, Gustave Roussy, FR

18.00-20.00 COCKTAIL POSTER SESSION